{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T05:04:02Z","timestamp":1735448642406,"version":"3.32.0"},"reference-count":20,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2024,12,25]]},"DOI":"10.3960\/jslrt.24039","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T22:12:59Z","timestamp":1735078379000},"page":"307-312","source":"Crossref","is-referenced-by-count":0,"title":["A lymph node lesion of hyper IL-6 syndrome mimicking plasmacytoma, IgG4-related disease, and Castleman disease"],"prefix":"10.3960","volume":"64","author":[{"given":"Kenta","family":"Matsui","sequence":"first","affiliation":[{"name":"Division of Pathology and Laboratory Medicine, JA Suzuka General Hospital, Suzuka, Mie, Japan,"},{"name":"Pathology Division, Mie University Hospital, Tsu, Mie, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Imai","sequence":"additional","affiliation":[{"name":"Pathology Division, Mie University Hospital, Tsu, Mie, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, JA Suzuka General Hospital, Suzuka, Mie, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Mizutani","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, JA Suzuka General Hospital, Suzuka, Mie, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori Filiz","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennosuke","family":"Karube","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manato","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, JA Suzuka General Hospital, Suzuka, Mie, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Usui","sequence":"additional","affiliation":[{"name":"Division of Pathology and Laboratory Medicine, JA Suzuka General Hospital, Suzuka, Mie, Japan,"},{"name":"Pathology Division, Mie University Hospital, Tsu, Mie, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiki","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, JA Suzuka General Hospital, Suzuka, Mie, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Murata","sequence":"additional","affiliation":[{"name":"Division of Pathology and Laboratory Medicine, JA Suzuka General Hospital, Suzuka, Mie, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Asano N, Sato Y. Rheumatoid lymphadenopathy with abundant IgG4(+) plasma cells: a case mimicking IgG4-related disease. J Clin Exp Hematop. 2012; 52: 57-61.","DOI":"10.3960\/jslrt.52.57"},{"key":"2","unstructured":"2 Terao T, Yamamoto K, Ikeuchi K <i>et al.<\/i> [Hyper-IL-6 syndrome mimicking IgG4-related disease]. Rinsho Ketsueki. 2019; 60: 392-397."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Masaki Y, Arita K, Sakai T <i>et al.<\/i> Castleman disease and TAFRO syndrome. Ann Hematol. 2022; 101: 485-490.","DOI":"10.1007\/s00277-022-04762-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Pham A, Mahindra A. Solitary plasmacytoma: a review of diagnosis and management. Curr Hematol Malig Rep. 2019; 14: 63-69.","DOI":"10.1007\/s11899-019-00499-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Li JW, Peng HL, Zhou XY, Wang JJ. Plasmablastic lymphoma: current knowledge and future directions. Front Immunol. 2024; 15: 1354604.","DOI":"10.3389\/fimmu.2024.1354604"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Mohammed Saleh MF, Kotb A, Abdallah GEM <i>et al.<\/i> Recent advances in diagnosis and therapy of angioimmunoblastic T cell lymphoma. Curr Oncol. 2021; 28: 5480-5498.","DOI":"10.3390\/curroncol28060456"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Sato Y, Yoshino T. IgG4-Related Lymphadenopathy. Int J Rheumatol. 2012; 2012: 572539.","DOI":"10.1155\/2012\/572539"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Cheuk W, Yuen HK, Chu SY <i>et al.<\/i> Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol. 2008; 32: 671-681.","DOI":"10.1097\/PAS.0b013e318157c068"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Deshpande V, Zen Y, Chan JK <i>et al.<\/i> Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012; 25: 1181-1192.","DOI":"10.1038\/modpathol.2012.72"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Satou A, Notohara K, Zen Y <i>et al.<\/i> Clinicopathological differential diagnosis of IgG4-related disease: A historical overview and a proposal of the criteria for excluding mimickers of IgG4-related disease. Pathol Int. 2020; 70: 391-402.","DOI":"10.1111\/pin.12932"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Carbone A, Borok M, Damania B <i>et al.<\/i> Castleman disease. Nat Rev Dis Primers. 2021; 7: 84.","DOI":"10.1038\/s41572-021-00317-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Nishikori A, Nishimura MF, Nishimura Y <i>et al.<\/i> Idiopathic plasmacytic lymphadenopathy forms an independent subtype of idiopathic multicentric Castleman disease. Int J Mol Sci. 2022; 23: 10301.","DOI":"10.3390\/ijms231810301"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 van Rhee F, Oksenhendler E, Srkalovic G <i>et al.<\/i> International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Adv. 2020; 4: 6039-6050.","DOI":"10.1182\/bloodadvances.2020003334"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Takeuchi K. Idiopathic plasmacytic lymphadenopathy: A conceptual history along with a translation of the original Japanese article published in 1980. J Clin Exp Hematop. 2022; 62: 79-84.","DOI":"10.3960\/jslrt.22011"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Manabe A, Igawa T, Takeuchi M <i>et al.<\/i> Immunohistochemical analysis of IgA expression differentiates IgG4-related disease from plasma cell-type Castleman disease. Med Mol Morphol. 2017; 50: 34-41.","DOI":"10.1007\/s00795-016-0145-4"},{"key":"16","unstructured":"16 Natkunam Y, Bhagat G, Chadburn A, <i>et al.<\/i> Hyperplasias arising in immune deficiency\/dysregulation. In: WHO Classification of Tumours Editorial Board. Haematolymphoid tumours [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; 2022. (WHO classification of tumours series, 5th ed.; vol. 11). Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/63."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Alaggio R, Amador C, Anagnostopoulos I, <i>et al.<\/i> The 5th edition of the World Health Organization classification of haematolymphoid tumours: Lymphoid neoplasms. Leukemia. 2022; 36: 1720-1748.","DOI":"10.1038\/s41375-022-01620-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Ortqvist A, Hedlund J, Wretlind B, Carlstr\u00f6m A, Kalin M. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia. Scand J Infect Dis. 1995; 27: 457-462.","DOI":"10.3109\/00365549509047046"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014; 6: a016295.","DOI":"10.1101\/cshperspect.a016295"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Hirano T. Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias. Int J Cell Cloning. 1991; 9: 166-184.","DOI":"10.1002\/stem.5530090303"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/4\/64_24039\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T05:04:27Z","timestamp":1735362267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/4\/64_24039\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,25]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.24039","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"type":"print","value":"1346-4280"},{"type":"electronic","value":"1880-9952"}],"subject":[],"published":{"date-parts":[[2024,12,25]]},"article-number":"24039"}}